Pharmacotherapy for childhood obesity: present and future prospects
- PMID: 22929210
- PMCID: PMC3522799
- DOI: 10.1038/ijo.2012.144
Pharmacotherapy for childhood obesity: present and future prospects
Abstract
Pediatric obesity is a serious medical condition associated with significant comorbidities during childhood and adulthood. Lifestyle modifications are essential for treating children with obesity, yet many have insufficient response to improve health with behavioral approaches alone. This review summarizes the relatively sparse data on pharmacotherapy for pediatric obesity and presents information on obesity medications in development. Most previously studied medications demonstrated, at best, modest effects on body weight and obesity-related conditions. It is to be hoped that the future will bring new drugs targeting specific obesity phenotypes that will allow clinicians to use etiology-specific, and therefore more effective, anti-obesity therapies.
References
- 
    - World Health Organization [Accessed: November 25, 2011];Obesity and Overweight Fact sheet Number 311. Web Page: http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
 
- 
    - Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA. 2010;303(3):242–9. - PubMed
 
- 
    - Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of High Body Mass Index in US Children and Adolescents, 2007–2008. Jama. 2010;303(3):242–249. - PubMed
 
- 
    - Rokholm B, Baker JL, Sorensen TI. The levelling off of the obesity epidemic since the year 1999 -a review of evidence and perspectives. Obes Rev. 2010 - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
 
        